48
views
0
recommends
+1 Recommend
3 collections
    1
    shares

      Call for Papers: Beyond Biology: The Crucial Role of Sex and Gender in Oncology

      Submit here before July 31, 2024

      About Oncology Research and Treatment: 2.4 Impact Factor I 3.3 CiteScore I 0.495 Scimago Journal & Country Rank (SJR)

      • Record: found
      • Abstract: found
      • Article: found

      Metastasiertes Nierenzellkarzinom: Überlegung zur Erstlinientherapie in den Zeiten einer SARS-CoV-2 Pandemie

      other
      *
      Karger Kompass Onkologie
      S. Karger AG

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          This letter summarizes recommendations from the interdisciplinary working group of renal tumors (IAGN) of the German Cancer Society for the systemic treatment of advanced/metastatic renal cell carcinoma in the context of the current SARS-CoV-2 pandemic.

          Related collections

          Author and article information

          Journal
          KKO
          10.1159/issn.2296-5416
          Karger Kompass Onkologie
          S. Karger AG
          2296-5416
          2296-5386
          2020
          December 2020
          27 November 2020
          : 7
          : 4
          : 195-196
          Affiliations
          Clinical Trial Unit Medical Oncology, Department of Hematology, Hemostasis, Oncology, Stem Cell Transplantation and Palliative Care, Hannover Medical School, Hannover, Deutschland
          Author notes
          *PD Dr. med. Philipp Ivanyi, Department of Hematology, Hemostasis, Oncology, Stem Cell Transplantation and Palliative Care, Hannover Medical School, Carl-Neuberg-Str. 1, Hannover (Deutschland), Ivanyi.Philipp@mh-hannover.de
          Article
          513115 Kompass Onkol 2020;7:195–196
          10.1159/000513115
          2d12dcf9-d2ee-4060-ab98-1fc2a15ed949
          © 2020 S. Karger GmbH, Freiburg

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          History
          Page count
          Pages: 2
          Categories
          Wissenstransfer

          Oncology & Radiotherapy,Pathology,Surgery,Obstetrics & Gynecology,Pharmacology & Pharmaceutical medicine,Hematology

          Comments

          Comment on this article